Clinical trial
Evaluation of the Efficacy of Artemether-lumefantrine and Dihydroartemisinin-piperaquine in Children With Uncomplicated Clinical Malaria in Rural Rwanda
NCT04767217 is registered in ClinicalTrials.gov with Jhpiego as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy of Artemether-lumefantrine and Dihydroartemisinin-piperaquine in Children With Uncomplicated Clinical Malaria in Rural Rwanda
- Lead sponsor
- Jhpiego
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 14, 2021
- Completion date
- January 31, 2024
- Enrollment
- 528 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
uncomplicated malaria